These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31088661)

  • 61. Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.
    Folsom AR; Lutsey PL; Heckbert SR; Poudel K; Basu S; Hoogeveen RC; Cushman M; Ballantyne CM
    J Thromb Haemost; 2018 Oct; 16(10):1964-1972. PubMed ID: 30007116
    [TBL] [Abstract][Full Text] [Related]  

  • 62. N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Nguyen K; Fan W; Bertoni A; Budoff MJ; Defilippi C; Lombardo D; Maisel A; Szklo M; Wong ND
    Am J Cardiol; 2020 Apr; 125(8):1194-1201. PubMed ID: 32106929
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE.
    Juraschek SP; Wang D; McEvoy JW; Harrap S; Harris K; Mancia G; Marre M; Neal B; Patel A; Poulter NR; Williams B; Chalmers J; Woodward M; Selvin E
    Int J Cardiol; 2022 Jul; 358():103-109. PubMed ID: 35439582
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT.
    Ascher SB; Scherzer R; de Lemos JA; Estrella MM; Jotwani VK; Garimella PS; Bullen AL; Ambrosius WT; Ballantyne CM; Nambi V; Killeen AA; Ix JH; Shlipak MG; Berry JD
    J Am Heart Assoc; 2022 Mar; 11(6):e023314. PubMed ID: 35243872
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study.
    Folsom AR; Nambi V; Bell EJ; Oluleye OW; Gottesman RF; Lutsey PL; Huxley RR; Ballantyne CM
    Stroke; 2013 Apr; 44(4):961-7. PubMed ID: 23471272
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiac biomarkers are influenced by dialysis characteristics.
    Sommerer C; Heckele S; Schwenger V; Katus HA; Giannitsis E; Zeier M
    Clin Nephrol; 2007 Dec; 68(6):392-400. PubMed ID: 18184522
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Repeated Measurements of Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Assess Long-Term Mortality Risk in Subjects with Osteoarthritis.
    Rehm M; Büchele G; Brenner RE; Günther KP; Brenner H; Koenig W; Rothenbacher D
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33562838
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Longitudinal changes of cardiac troponin and inflammation reflect progressive myocyte stretch and likelihood for hypertension in a Black male cohort: The SABPA study.
    Jansen van Vuren E; Malan L; von Känel R; Lammertyn L; Cockeran M; Malan NT
    Hypertens Res; 2019 May; 42(5):708-716. PubMed ID: 30626934
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The value of N-terminal pro-B-type natriuretic peptide in determining antihypertensive benefit: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Welsh P; Poulter NR; Chang CL; Sever PS; Sattar N;
    Hypertension; 2014 Mar; 63(3):507-13. PubMed ID: 24324046
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide.
    Jungbauer CG; Riedlinger J; Buchner S; Birner C; Resch M; Lubnow M; Debl K; Buesing M; Huedig H; Riegger G; Luchner A
    Clin Chem Lab Med; 2011 Nov; 49(11):1899-906. PubMed ID: 21892905
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.
    Srivastava PK; Pradhan AD; Cook NR; Ridker PM; Everett BM
    Am J Cardiol; 2016 Feb; 117(3):376-81. PubMed ID: 26739393
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
    Vergaro G; Gentile F; Aimo A; Januzzi JL; Richards AM; Lam CSP; de Boer RA; Meems LMG; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; Emdin M
    ESC Heart Fail; 2022 Aug; 9(4):2084-2095. PubMed ID: 35510529
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adults.
    Liu S; Kim ED; Wu A; Meyer ML; Cheng S; Hoogeveen RC; Ballantyne CM; Tanaka H; Heiss G; Selvin E; Matsushita K
    PLoS One; 2019; 14(2):e0212892. PubMed ID: 30811490
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Highly sensitive cardiac troponin T and long-term mortality in a population of community-derived perimenopausal women: nested case-control study.
    Cramer GE; Brouwer MA; Vader HL; de Boer MJ; Pop GA; Pop VJ; Verheugt FW
    Heart; 2013 Apr; 99(8):528-33. PubMed ID: 23315610
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up.
    Koenig W; Breitling LP; Hahmann H; Wüsten B; Brenner H; Rothenbacher D
    Clin Chem; 2012 Aug; 58(8):1215-24. PubMed ID: 22634379
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An
    Seidelmann SB; Vardeny O; Claggett B; Yu B; Shah AM; Ballantyne CM; Selvin E; MacRae CA; Boerwinkle E; Solomon SD
    J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28341776
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Associations of Cardiac Biomarkers With Peripheral Artery Disease and Peripheral Neuropathy in US Adults Without Prevalent Cardiovascular Disease.
    Hicks CW; Wang D; McDermott K; Matsushita K; Tang O; Echouffo-Tcheugui JB; McEvoy JW; Christenson RH; Selvin E
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1583-1591. PubMed ID: 37317848
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
    Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
    Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.